The global market for structural heart closure devices will grow rapidly in most countries covered through 2028, driven by strong clinical data, the availability of reimbursement, a growing body of trained physicians, and the uptake of premium priced technologies, especially in the PFO and LAA closure device spaces.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the global structural heart closure device market across a 10-year period.


The global market for structural heart closure devices will grow rapidly throughout the forecast period.

Which segment contributed the most to global revenues in 2019?

Which segments are contributing the most to overall global growth?

What are the different growth trends by region? How has the reimbursement landscape changed for structural heart closure procedures in different geographies?

Results from the NHS Clinical Commissioning Policy evaluation program will have a strong impact on procedure volumes in the UK.

Which procedures were affected by the Clinical Commissioning Policy in the UK?

What is the impact of the evaluation program on the UK structural heart closure device market?

Clinical data and treatment guidelines for procedures like LAA and PFO closures will drive the use of percutaneous closure devices. 

What are the most recent trials and studies that have taken place in the dialysis access treatment device space? 

How will clinical trial results impact this market?

The LAA closure device segment represents a significant market opportunity for manufacturers in the structural heart closure device space.

What are the differences between epicardial and endocardial LAA closure devices and how will these differences affect trends going forward?

How will the global endocardial LAA market be affected by the PMDA approval of Boston Scientific's WATCHMAN device in 2019? How can other companies challenge Boston Scientific in this high-growth market?

The global market for PFO closure devices has experienced turbulence in the past but is positioned for growth given recent positive clinical data and updated reimbursement policies.

What new clinical evidence challenges the historically troubled body of evidence for PFO closure? 

How is the patient population for PFO closure defined and how is it different between geographies?

Which country will be impacted by the changes in the reimbursement policies for PFO closure procedure and how will this affect the procedure volumes going forward?

Table of contents

  • Global
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • End-User Insights
      • Geographies Covered
      • Procedures and Products Covered
    • Key Report Updates
    • Structural Heart Closure Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Mergers, Acquisitions, and Partnerships
        • Product Portfolio Management
        • Product Improvements and Innovations
        • Distribution and Sales Network
        • Pricing Strategies and Purchasing Options
        • Physician Training and Marketing
      • Market Developments
    • Congenital Heart Defect Closure Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Atrial Septal Defect Closure Device Market
        • Patent Ductus Arteriosus Closure Device Market
        • Ventricular Septal Defect Closure Device Market
        • US Market
        • European Market
        • Japanese Market
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Portfolio Management
        • Product Improvements and Innovations
        • Pricing Strategies and Purchasing Options
    • Patent Foramen Ovale Closure Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Left Atrial Appendage Closure Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Endocardial Left Atrial Appendage Closure Devices
        • Epicardial Left Atrial Appendage Closure Devices
        • US Market
        • European Market
        • Japanese Market
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Product Portfolio Management
        • Product Improvements and Innovations
        • Physician Training and Marketing
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Sangeetha Iyer, Pharm.D

Sangeetha Iyer is an analyst within the Cardiovascular Medtech Insights team at Decision Resource Group, specializing in structural heart closure and vascular access device markerts across the Asia Pacific region, as well as medical device pricing and regulations in China and Japan. Sangeetha has represnted India at the European Society of Cardiology confrerence in Greece(2016) and Sweden(2017), where her research poster was awarded the top prize. Sangeetha holds a Doctor of Pharmacy degree from the Manipal Academy of Higher Education. Follow Sangeetha on twitter: @Slyer_DRG


Related Reports

Structural Heart Closure Devices | Medtech 360 | Market Insights | Asia Pacific (Supplemental)

The Asia Pacific market for structural heart closure devices will grow robustly, fueled by strong expansion of the 

View Details